16
Views
9
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Klebsiella pneumoniae LO10 Producing Extended-Spectrum Beta-lactamase SHV-12 in Saudi Arabia

Pages 709-713 | Published online: 18 Jul 2013

References

  • Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and path-ogenicity factors. Clin Microbiol Rev 1998; 11: 589-603. 2Yinnon A M, Butnaru A, Raveh D, Jerassy Z, Rudensky B. Klebsiella bacteremia: community versus nosocomial infec-tion. QJM 1996; 89: 933–941.
  • Hable KA, Matsen JM, Wheeler DJ, Hunt CE, Quie PG. Klebsiella type 33 septicemia in an infant intensive care unit. J Pediatr 1972; 80: 920-924. 'Hobson RP, MacKenzie FM, Gould IM. An outbreak of mul-tiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996; 33: 249–262.
  • Margreet GF, Inge CG, Irma MK, Patty JER, Alewijn 0, Arnold GV, et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. An-timicrob Agents Chemother 2005; 49 (7): 2879–2886.
  • Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is asso-ciated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane pro-tein. Antimicrob Agents Chemother 1997; 41: 563–569.
  • Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV 13-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. An-timicrob Agents Chemother. 1997; 41: 943–949.
  • Kim J, Kwon Y, Pai H, Kim JW, Cho DT. Survey of Kleb-siella pneumoniae strains producing extended-spectrum 13-lac-tamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998; 36: 1446–1449.
  • Yan JJ, Wu SM, Tsai SH, Wu JJ, Su UM. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae pro-ducing extended-spectrum 13-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000; 44: 1438–1442
  • Cobo J, Morosini MI, Pintado V, Tato M, Samaranch N, Baquero F, Canton R. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 2008; 60 (3): 319–22
  • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Com-mittee for Clinical Laboratory Standards, Wayne, Pa. 1997.
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-57). National Com-mittee for Clinical Laboratory Standards; Wayne, Pa. 1997.
  • Gaillot O, Maruéjouls C, Abachin E, Lecuru F, Arlet G, Si-monet M, Berche P. .Nosocomial outbreak of Klebsiella pneu-moniae producing shv-5 extended-spectrum 13-lactamse originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36 (5) 1357–1360.
  • Trieu-Cuot P, Courvalin P. Transposition behavior of IS15 and its progenitor I515-delta:are cointegrates exclusive end prod-ucts? Plasmid 1985; 14 (1): 80–89.
  • Sambrook J, Russell D. Molecular cloning: a laboratory manual, 3rd ed. 2001; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
  • Mabilat C, Goussard S. PCR detection and identification of genes for extended-spectrum 13-lactamases. In Persing DH, Smith TF, Tenover FC, White TJ (ed.), Diagnostic molecular mi-crobiology: principles and applications. American Society for Mi-crobiology, Washington, D.C. 1993; 553-559.
  • Goldmann DA, Leclair J, Macone A. Bacterial coloniza-tion of neonates admitted to an intensive care environment. J Pediatr 1978; 93: 288–293.
  • Pena C, Pujol M, Ardanuy C, et al. Epidemiology and suc-cessful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum beta-lactamases: Are we losing the battle? Aust J Med Sci 1995; 16: 16-25.
  • Nathisuwan S, Burgess DS, Lewis JS. Extended spectrum beta-lactamases: epidemiology, detection and treatment. Phar-macotherapy 2001; 21: 920–928.
  • Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264:375.
  • Coulter C, Faoagali JC, Doige S, Bodman J, George N. Hand culture surveillance to investigate transmission of epidemic extended-spectrum beta-lactamase producing Klebsiella pneu-moniae in a major intensive care unit. Aust NZ J Med 1995; 25: 572. (abstract).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.